Hypomagnesemia risk factors: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) |
Hudakarman (talk | contribs) No edit summary |
||
Line 6: | Line 6: | ||
== Risk factors == | == Risk factors == | ||
The following patients have high risk of hypoglycemia development: | The following patients have high risk of hypoglycemia development: | ||
*Critically ill patients | *Critically ill patients | ||
* Hospitalized patients | * Hospitalized patients | ||
* Burned patients | * Burned patients<ref name="pmid15633562">{{cite journal| author=Durán-Vega HC, Romero-Aviña FJ, Gutiérrez-Salgado JE, Silva-Díaz T, Ramos-Durón LE, Carrera-Gómez FJ| title=[Risk factors for development of hypomagnesemia in the burned patient]. | journal=Gac Med Mex | year= 2004 | volume= 140 | issue= 6 | pages= 577-82 | pmid=15633562 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15633562 }}</ref> | ||
*Head and Neck Cancer Patients Treated with Cetuximab<ref name="pmid27683640">{{cite journal| author=Enokida T, Suzuki S, Wakasugi T, Yamazaki T, Okano S, Tahara M| title=Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab. | journal=Front Oncol | year= 2016 | volume= 6 | issue= | pages= 196 | pmid=27683640 | doi=10.3389/fonc.2016.00196 | pmc=5021713 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27683640 }}</ref> | |||
<br /> | <br /> |
Revision as of 21:05, 6 April 2020
Hypomagnesemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypomagnesemia risk factors On the Web |
American Roentgen Ray Society Images of Hypomagnesemia risk factors |
Risk calculators and risk factors for Hypomagnesemia risk factors |
Overview
Risk factors
The following patients have high risk of hypoglycemia development:
- Critically ill patients
- Hospitalized patients
- Burned patients[1]
- Head and Neck Cancer Patients Treated with Cetuximab[2]
References
- ↑ Durán-Vega HC, Romero-Aviña FJ, Gutiérrez-Salgado JE, Silva-Díaz T, Ramos-Durón LE, Carrera-Gómez FJ (2004). "[Risk factors for development of hypomagnesemia in the burned patient]". Gac Med Mex. 140 (6): 577–82. PMID 15633562.
- ↑ Enokida T, Suzuki S, Wakasugi T, Yamazaki T, Okano S, Tahara M (2016). "Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab". Front Oncol. 6: 196. doi:10.3389/fonc.2016.00196. PMC 5021713. PMID 27683640.